Sarcena, Martin L.

HRN: 21-40-13  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/28/2023
CEFTRIAXONE 1G (VIAL)
01/28/2023
02/03/2023
IVT
2g
OD
Pneumonia
Waiting Final Action 
01/28/2023
AZITHROMYCIN 500MG TABLET (TAB)
01/28/2023
02/03/2023
PO
500mgtab
OD
Pneumonia
Waiting Final Action 
02/09/2023
CEFTAZIDIME 1GM (VIAL)
02/09/2023
02/15/2023
IV
1g
Q8
CAP MR With Pleural Effusion Right
Waiting Final Action 
05/04/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/04/2023
05/04/2023
IV
4.5g
Loading Dose
Sepsis
Waiting Final Action 
05/04/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/04/2023
05/10/2023
IV
2.25g
Q6
Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: